nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine monophosphate—CREB1—FSH signaling pathway—CGA—conduct disorder	0.0292	0.0411	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—brain—conduct disorder	0.0245	0.0991	CbGeAlD
Adenosine monophosphate—S-Adenosylmethionine—COMT—conduct disorder	0.0235	0.563	CrCbGaD
Adenosine monophosphate—PYGL—brain—conduct disorder	0.0234	0.0948	CbGeAlD
Adenosine monophosphate—ADCY1—brain—conduct disorder	0.023	0.0928	CbGeAlD
Adenosine monophosphate—ADCY1—GABA receptor activation—GABRA2—conduct disorder	0.0214	0.0301	CbGpPWpGaD
Adenosine monophosphate—PDE4D—TSH signaling pathway—CGA—conduct disorder	0.0207	0.0291	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0192	0.0269	CbGpPWpGaD
Adenosine monophosphate—HINT1—brain—conduct disorder	0.0186	0.0751	CbGeAlD
Adenosine monophosphate—Flavin adenine dinucleotide—MAOA—conduct disorder	0.0183	0.437	CrCbGaD
Adenosine monophosphate—ACSS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0177	0.025	CbGpPWpGaD
Adenosine monophosphate—SRC—FSH signaling pathway—CGA—conduct disorder	0.0171	0.0241	CbGpPWpGaD
Adenosine monophosphate—ACSS2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0168	0.0237	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—brain—conduct disorder	0.0159	0.0644	CbGeAlD
Adenosine monophosphate—ACSS1—brain—conduct disorder	0.0154	0.0624	CbGeAlD
Adenosine monophosphate—PIM1—brain—conduct disorder	0.015	0.0606	CbGeAlD
Adenosine monophosphate—ACSS2—brain—conduct disorder	0.0148	0.0598	CbGeAlD
Adenosine monophosphate—APRT—brain—conduct disorder	0.0148	0.0598	CbGeAlD
Adenosine monophosphate—ACSL1—brain—conduct disorder	0.0147	0.0594	CbGeAlD
Adenosine monophosphate—CREB1—TSH signaling pathway—CGA—conduct disorder	0.0143	0.0201	CbGpPWpGaD
Adenosine monophosphate—CREB1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0143	0.0201	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—brain—conduct disorder	0.0139	0.0563	CbGeAlD
Adenosine monophosphate—CREB1—brain—conduct disorder	0.0139	0.0563	CbGeAlD
Adenosine monophosphate—ACSS1—Signaling events mediated by HDAC Class III—EP300—conduct disorder	0.0133	0.0188	CbGpPWpGaD
Adenosine monophosphate—PDE4D—brain—conduct disorder	0.013	0.0527	CbGeAlD
Adenosine monophosphate—ACSS2—Signaling events mediated by HDAC Class III—EP300—conduct disorder	0.0127	0.0178	CbGpPWpGaD
Adenosine monophosphate—PDE4D—G alpha (s) signalling events—CGA—conduct disorder	0.0125	0.0176	CbGpPWpGaD
Adenosine monophosphate—CREB1—Glucocorticoid receptor regulatory network—CGA—conduct disorder	0.012	0.0169	CbGpPWpGaD
Adenosine monophosphate—ADCY1—G alpha (s) signalling events—CGA—conduct disorder	0.0116	0.0163	CbGpPWpGaD
Adenosine monophosphate—PDE4B—G alpha (s) signalling events—CGA—conduct disorder	0.011	0.0155	CbGpPWpGaD
Adenosine monophosphate—CREB1—NOTCH2 intracellular domain regulates transcription—EP300—conduct disorder	0.0108	0.0152	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00985	0.0139	CbGpPWpGaD
Adenosine monophosphate—SRC—brain—conduct disorder	0.0098	0.0396	CbGeAlD
Adenosine monophosphate—PIM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00975	0.0137	CbGpPWpGaD
Adenosine monophosphate—ADK—brain—conduct disorder	0.00967	0.0391	CbGeAlD
Adenosine monophosphate—ACSS1—Biological oxidations—COMT—conduct disorder	0.00949	0.0134	CbGpPWpGaD
Adenosine monophosphate—ACSS1—Biological oxidations—MAOA—conduct disorder	0.00943	0.0133	CbGpPWpGaD
Adenosine monophosphate—ACSS2—Biological oxidations—COMT—conduct disorder	0.009	0.0127	CbGpPWpGaD
Adenosine monophosphate—ACSS2—Biological oxidations—MAOA—conduct disorder	0.00894	0.0126	CbGpPWpGaD
Adenosine monophosphate—SRC—TSH signaling pathway—CGA—conduct disorder	0.00837	0.0118	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0074	0.0104	CbGpPWpGaD
Adenosine monophosphate—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00734	0.0103	CbGpPWpGaD
Adenosine monophosphate—PIM1—Validated targets of C-MYC transcriptional activation—EP300—conduct disorder	0.00719	0.0101	CbGpPWpGaD
Adenosine monophosphate—PDE4B—brain—conduct disorder	0.00687	0.0278	CbGeAlD
Adenosine monophosphate—PIM1—C-MYB transcription factor network—EP300—conduct disorder	0.00685	0.00963	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00631	0.00887	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00621	0.00874	CbGpPWpGaD
Adenosine monophosphate—AMPD1—Metabolism—CGA—conduct disorder	0.00594	0.00835	CbGpPWpGaD
Adenosine monophosphate—SRC—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—conduct disorder	0.00569	0.00801	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Neuronal System—GABRA2—conduct disorder	0.00567	0.00798	CbGpPWpGaD
Adenosine monophosphate—CREB1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00552	0.00777	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Circadian rythm related genes—SLC6A4—conduct disorder	0.0053	0.00746	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by NOTCH2—EP300—conduct disorder	0.00506	0.00712	CbGpPWpGaD
Adenosine monophosphate—FBP1—Metabolism—CGA—conduct disorder	0.00505	0.0071	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Circadian rythm related genes—DRD4—conduct disorder	0.00498	0.00701	CbGpPWpGaD
Adenosine monophosphate—PYGL—Metabolism—CGA—conduct disorder	0.00475	0.00668	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Circadian rythm related genes—SLC6A4—conduct disorder	0.00468	0.00659	CbGpPWpGaD
Adenosine monophosphate—SRC—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00456	0.00641	CbGpPWpGaD
Adenosine monophosphate—ACSL1—PPARA activates gene expression—EP300—conduct disorder	0.00455	0.00639	CbGpPWpGaD
Adenosine monophosphate—APRT—Metabolism—CGA—conduct disorder	0.0045	0.00633	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00445	0.00626	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Circadian rythm related genes—DRD4—conduct disorder	0.0044	0.00619	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Innate Immune System—MB21D1—conduct disorder	0.00439	0.00617	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by VEGF—WASF1—conduct disorder	0.0043	0.00605	CbGpPWpGaD
Adenosine monophosphate—CREB1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00428	0.00602	CbGpPWpGaD
Adenosine monophosphate—CREB1—Neuronal System—GABRA2—conduct disorder	0.00423	0.00595	CbGpPWpGaD
Adenosine monophosphate—ADCY1—G alpha (i) signalling events—DRD4—conduct disorder	0.00389	0.00547	CbGpPWpGaD
Adenosine monophosphate—ACSS1—Metabolism—CGA—conduct disorder	0.0036	0.00506	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00356	0.00501	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00354	0.00498	CbGpPWpGaD
Adenosine monophosphate—CREB1—Circadian rythm related genes—SLC6A4—conduct disorder	0.00349	0.00491	CbGpPWpGaD
Adenosine monophosphate—ACSS2—Metabolism—CGA—conduct disorder	0.00341	0.0048	CbGpPWpGaD
Adenosine monophosphate—CREB1—Circadian rythm related genes—DRD4—conduct disorder	0.00328	0.00462	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—MB21D1—conduct disorder	0.00327	0.0046	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Innate Immune System—POLR3A—conduct disorder	0.00322	0.00453	CbGpPWpGaD
Adenosine monophosphate—CREB1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00322	0.00453	CbGpPWpGaD
Adenosine monophosphate—CREB1—Circadian Clock—EP300—conduct disorder	0.0032	0.0045	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00307	0.00431	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00305	0.00429	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Direct p53 effectors—EP300—conduct disorder	0.00304	0.00427	CbGpPWpGaD
Adenosine monophosphate—CREB1—ATF-2 transcription factor network—EP300—conduct disorder	0.00303	0.00426	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00302	0.00425	CbGpPWpGaD
Adenosine monophosphate—ADK—Metabolism—CGA—conduct disorder	0.0029	0.00408	CbGpPWpGaD
Adenosine monophosphate—CREB1—Validated targets of C-MYC transcriptional repression—EP300—conduct disorder	0.00287	0.00404	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Metabolism—CGA—conduct disorder	0.00281	0.00395	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Metabolism—CGA—conduct disorder	0.00277	0.00389	CbGpPWpGaD
Adenosine monophosphate—CREB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00277	0.00389	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Neuronal System—COMT—conduct disorder	0.00273	0.00384	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Neuronal System—MAOA—conduct disorder	0.00271	0.00381	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Innate Immune System—WASF1—conduct disorder	0.00271	0.00381	CbGpPWpGaD
Adenosine monophosphate—AMPD1—Metabolism—COMT—conduct disorder	0.00268	0.00377	CbGpPWpGaD
Adenosine monophosphate—AMPD1—Metabolism—MAOA—conduct disorder	0.00266	0.00374	CbGpPWpGaD
Adenosine monophosphate—CREB1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00266	0.00374	CbGpPWpGaD
Adenosine monophosphate—CREB1—AP-1 transcription factor network—EP300—conduct disorder	0.00264	0.00371	CbGpPWpGaD
Adenosine monophosphate—CREB1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00264	0.00371	CbGpPWpGaD
Adenosine monophosphate—CREB1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00262	0.00369	CbGpPWpGaD
Adenosine monophosphate—PDE4D—GPCR downstream signaling—CGA—conduct disorder	0.00256	0.00361	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—MB21D1—conduct disorder	0.00256	0.00359	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—POLR3A—conduct disorder	0.0024	0.00338	CbGpPWpGaD
Adenosine monophosphate—ADCY1—GPCR downstream signaling—CGA—conduct disorder	0.00237	0.00334	CbGpPWpGaD
Adenosine monophosphate—CREB1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00235	0.0033	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—CGA—conduct disorder	0.00233	0.00328	CbGpPWpGaD
Adenosine monophosphate—CREB1—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.00233	0.00327	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—CGA—conduct disorder	0.00231	0.00325	CbGpPWpGaD
Adenosine monophosphate—FBP1—Metabolism—COMT—conduct disorder	0.00228	0.00321	CbGpPWpGaD
Adenosine monophosphate—FBP1—Metabolism—MAOA—conduct disorder	0.00226	0.00318	CbGpPWpGaD
Adenosine monophosphate—PDE4B—GPCR downstream signaling—CGA—conduct disorder	0.00226	0.00318	CbGpPWpGaD
Adenosine monophosphate—CREB1—Androgen receptor signaling pathway—EP300—conduct disorder	0.00218	0.00306	CbGpPWpGaD
Adenosine monophosphate—SRC—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00216	0.00304	CbGpPWpGaD
Adenosine monophosphate—SRC—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00216	0.00304	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—CGA—conduct disorder	0.00216	0.00303	CbGpPWpGaD
Adenosine monophosphate—PYGL—Metabolism—COMT—conduct disorder	0.00214	0.00301	CbGpPWpGaD
Adenosine monophosphate—PYGL—Metabolism—MAOA—conduct disorder	0.00213	0.00299	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—CGA—conduct disorder	0.00205	0.00288	CbGpPWpGaD
Adenosine monophosphate—CREB1—Neuronal System—COMT—conduct disorder	0.00204	0.00286	CbGpPWpGaD
Adenosine monophosphate—APRT—Metabolism—COMT—conduct disorder	0.00203	0.00286	CbGpPWpGaD
Adenosine monophosphate—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00203	0.00286	CbGpPWpGaD
Adenosine monophosphate—CREB1—Neuronal System—MAOA—conduct disorder	0.00202	0.00284	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—WASF1—conduct disorder	0.00202	0.00284	CbGpPWpGaD
Adenosine monophosphate—APRT—Metabolism—MAOA—conduct disorder	0.00202	0.00284	CbGpPWpGaD
Adenosine monophosphate—SRC—Regulation of Androgen receptor activity—EP300—conduct disorder	0.00193	0.00272	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—MB21D1—conduct disorder	0.00192	0.0027	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—MB21D1—conduct disorder	0.00191	0.00268	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—CGA—conduct disorder	0.0019	0.00268	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—POLR3A—conduct disorder	0.00188	0.00264	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—WASF1—conduct disorder	0.00185	0.00261	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by NOTCH—EP300—conduct disorder	0.00185	0.0026	CbGpPWpGaD
Adenosine monophosphate—SRC—Kit receptor signaling pathway—EP300—conduct disorder	0.00177	0.00249	CbGpPWpGaD
Adenosine monophosphate—SRC—Notch Signaling Pathway—EP300—conduct disorder	0.00173	0.00243	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Circadian rythm related genes—EP300—conduct disorder	0.00172	0.00242	CbGpPWpGaD
Adenosine monophosphate—ACSS1—Metabolism—COMT—conduct disorder	0.00162	0.00228	CbGpPWpGaD
Adenosine monophosphate—ACSS1—Metabolism—MAOA—conduct disorder	0.00161	0.00227	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—CGA—conduct disorder	0.00161	0.00226	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—WASF1—conduct disorder	0.00158	0.00222	CbGpPWpGaD
Adenosine monophosphate—ACSS2—Metabolism—COMT—conduct disorder	0.00154	0.00217	CbGpPWpGaD
Adenosine monophosphate—ACSS2—Metabolism—MAOA—conduct disorder	0.00153	0.00215	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—WASF1—conduct disorder	0.00152	0.00214	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—CGA—conduct disorder	0.00152	0.00214	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Circadian rythm related genes—EP300—conduct disorder	0.00152	0.00214	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—CGA—conduct disorder	0.00144	0.00203	CbGpPWpGaD
Adenosine monophosphate—PDE4D—GPCR downstream signaling—DRD4—conduct disorder	0.00144	0.00202	CbGpPWpGaD
Adenosine monophosphate—CREB1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00143	0.00201	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—POLR3A—conduct disorder	0.00141	0.00198	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—POLR3A—conduct disorder	0.0014	0.00197	CbGpPWpGaD
Adenosine monophosphate—CREB1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00139	0.00196	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—CGA—conduct disorder	0.00138	0.00193	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00136	0.00192	CbGpPWpGaD
Adenosine monophosphate—ADCY1—GPCR downstream signaling—DRD4—conduct disorder	0.00133	0.00187	CbGpPWpGaD
Adenosine monophosphate—ADK—Metabolism—COMT—conduct disorder	0.00131	0.00184	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—DRD4—conduct disorder	0.0013	0.00183	CbGpPWpGaD
Adenosine monophosphate—ADK—Metabolism—MAOA—conduct disorder	0.0013	0.00183	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—DRD4—conduct disorder	0.0013	0.00182	CbGpPWpGaD
Adenosine monophosphate—SRC—Androgen receptor signaling pathway—EP300—conduct disorder	0.00128	0.00179	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—CGA—conduct disorder	0.00127	0.00179	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Metabolism—COMT—conduct disorder	0.00127	0.00178	CbGpPWpGaD
Adenosine monophosphate—PDE4B—GPCR downstream signaling—DRD4—conduct disorder	0.00126	0.00178	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Metabolism—MAOA—conduct disorder	0.00126	0.00177	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Metabolism—COMT—conduct disorder	0.00125	0.00176	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Metabolism—MAOA—conduct disorder	0.00124	0.00174	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00122	0.00172	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CGA—conduct disorder	0.00121	0.0017	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—DRD4—conduct disorder	0.00121	0.0017	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0012	0.00169	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—WASF1—conduct disorder	0.00118	0.00167	CbGpPWpGaD
Adenosine monophosphate—CREB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00118	0.00166	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—WASF1—conduct disorder	0.00118	0.00166	CbGpPWpGaD
Adenosine monophosphate—FBP1—Disease—EP300—conduct disorder	0.00117	0.00164	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—WASF1—conduct disorder	0.00116	0.00163	CbGpPWpGaD
Adenosine monophosphate—AMPD1—Metabolism—EP300—conduct disorder	0.00115	0.00162	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—DRD4—conduct disorder	0.00115	0.00162	CbGpPWpGaD
Adenosine monophosphate—CREB1—Circadian rythm related genes—EP300—conduct disorder	0.00113	0.0016	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MB21D1—conduct disorder	0.00112	0.00157	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—WASF1—conduct disorder	0.0011	0.00155	CbGpPWpGaD
Adenosine monophosphate—PYGL—Disease—EP300—conduct disorder	0.0011	0.00154	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—DRD4—conduct disorder	0.00107	0.0015	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—WASF1—conduct disorder	0.00102	0.00144	CbGpPWpGaD
Adenosine monophosphate—FBP1—Metabolism—EP300—conduct disorder	0.000977	0.00137	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—WASF1—conduct disorder	0.000971	0.00137	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CGA—conduct disorder	0.00095	0.00134	CbGpPWpGaD
Adenosine monophosphate—PDE4D—GPCR downstream signaling—HTR2A—conduct disorder	0.000937	0.00132	CbGpPWpGaD
Adenosine monophosphate—SRC—TGF-beta Signaling Pathway—EP300—conduct disorder	0.000931	0.00131	CbGpPWpGaD
Adenosine monophosphate—PYGL—Metabolism—EP300—conduct disorder	0.000919	0.00129	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—DRD4—conduct disorder	0.0009	0.00127	CbGpPWpGaD
Adenosine monophosphate—APRT—Metabolism—EP300—conduct disorder	0.000871	0.00123	CbGpPWpGaD
Adenosine monophosphate—ADCY1—GPCR downstream signaling—HTR2A—conduct disorder	0.000867	0.00122	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—HTR2A—conduct disorder	0.000851	0.0012	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—HTR2A—conduct disorder	0.000845	0.00119	CbGpPWpGaD
Adenosine monophosphate—PDE4B—GPCR downstream signaling—HTR2A—conduct disorder	0.000825	0.00116	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—POLR3A—conduct disorder	0.000819	0.00115	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—DRD4—conduct disorder	0.000807	0.00114	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—HTR2A—conduct disorder	0.000788	0.00111	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—DRD4—conduct disorder	0.00077	0.00108	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—WASF1—conduct disorder	0.000761	0.00107	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—HTR2A—conduct disorder	0.000749	0.00105	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—DRD4—conduct disorder	0.000713	0.001	CbGpPWpGaD
Adenosine monophosphate—ACSS1—Metabolism—EP300—conduct disorder	0.000696	0.00098	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—HTR2A—conduct disorder	0.000695	0.000978	CbGpPWpGaD
Adenosine monophosphate—SRC—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000692	0.000974	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—WASF1—conduct disorder	0.000689	0.00097	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—COMT—conduct disorder	0.000688	0.000967	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—MAOA—conduct disorder	0.000683	0.00096	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—DRD4—conduct disorder	0.000678	0.000954	CbGpPWpGaD
Adenosine monophosphate—ACSS2—Metabolism—EP300—conduct disorder	0.00066	0.000929	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Innate Immune System—EP300—conduct disorder	0.000655	0.000921	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—HTR2A—conduct disorder	0.000587	0.000826	CbGpPWpGaD
Adenosine monophosphate—ADK—Metabolism—EP300—conduct disorder	0.000561	0.00079	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CGA—conduct disorder	0.000556	0.000782	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—EP300—conduct disorder	0.000553	0.000778	CbGpPWpGaD
Adenosine monophosphate—ACSL1—Metabolism—EP300—conduct disorder	0.000544	0.000765	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Metabolism—EP300—conduct disorder	0.000535	0.000753	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—DRD4—conduct disorder	0.000532	0.000748	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—HTR2A—conduct disorder	0.000527	0.000741	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—HTR2A—conduct disorder	0.000503	0.000707	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—EP300—conduct disorder	0.000488	0.000687	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—HTR2A—conduct disorder	0.000465	0.000655	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—EP300—conduct disorder	0.000448	0.00063	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—WASF1—conduct disorder	0.000446	0.000627	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—HTR2A—conduct disorder	0.000443	0.000623	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—EP300—conduct disorder	0.000381	0.000536	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—EP300—conduct disorder	0.000368	0.000518	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—EP300—conduct disorder	0.000352	0.000495	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—HTR2A—conduct disorder	0.000347	0.000488	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—EP300—conduct disorder	0.000324	0.000455	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—EP300—conduct disorder	0.000318	0.000447	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—DRD4—conduct disorder	0.000311	0.000438	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—EP300—conduct disorder	0.000295	0.000415	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—EP300—conduct disorder	0.000286	0.000402	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—EP300—conduct disorder	0.000284	0.0004	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—EP300—conduct disorder	0.000279	0.000393	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—EP300—conduct disorder	0.000266	0.000375	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—EP300—conduct disorder	0.000262	0.000369	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—EP300—conduct disorder	0.000247	0.000347	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—EP300—conduct disorder	0.000234	0.00033	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—HTR2A—conduct disorder	0.000203	0.000286	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—EP300—conduct disorder	0.000184	0.000259	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—EP300—conduct disorder	0.000167	0.000234	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—EP300—conduct disorder	0.000154	0.000216	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—EP300—conduct disorder	0.000108	0.000151	CbGpPWpGaD
